speb/financial-data huggingface dataset:
CLST cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 5001000.00
CLST balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 14693000.00
CLST balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 14693000.00
CLST cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 5001000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -171000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 489000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 489000.00
CLST income_statement (quarterly, 2025-09-30) — Net Interest Income: 2450000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -15294000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 5000000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 5000000.00
CLST cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -108000.00
CLST balance_sheet (quarterly, 2025-09-30) — Net PPE: 5954000.00
CLST cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -85000.00
CLST balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 81585000.00
CLST income_statement (quarterly, 2025-09-30) — Normalized Income: 489816.36
CLST income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 220000.00
CLST cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 912000.00
CLST cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -4000.00
CLST income_statement (quarterly, 2025-09-30) — Operating Revenue: 2742000.00
CLST balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4129604.00
CLST balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2649000.00
CLST balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -5260000.00
CLST cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 45000.00
CLST income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 397000.00
CLST balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 44853000.00
CLST income_statement (quarterly, 2025-09-30) — Other Special Charges: 1000.00
CLST balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CLST income_statement (quarterly, 2025-09-30) — Pretax Income: 599000.00
CLST income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 91000.00
CLST cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -16262000.00
CLST cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -85000.00
CLST balance_sheet (quarterly, 2025-09-30) — Receivables: 861000.00
CLST income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 107000.00
CLST cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -171000.00
CLST balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 51456000.00
CLST income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1435000.00
CLST cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 968000.00
CLST cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
CLST income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 35000.00
CLST income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1470000.00
CLST balance_sheet (quarterly, 2025-09-30) — Share Issued: 4129604.00
CLST income_statement (quarterly, 2025-09-30) — Special Income Charges: -1000.00
CLST cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 239000.00
CLST balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 81585000.00
CLST balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 81585000.00
CLST income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -183.64
CLST income_statement (quarterly, 2025-09-30) — Tax Provision: 110000.00
CLST income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.18
CLST balance_sheet (quarterly, 2025-09-30) — Total Assets: 283834000.00
CLST balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 96278000.00
CLST balance_sheet (quarterly, 2025-09-30) — Total Debt: 14693000.00
CLST balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 81585000.00
CLST balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 202249000.00
CLST income_statement (quarterly, 2025-09-30) — Total Unusual Items: -1000.00
CLST income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -1000.00
CLST income_statement (annual, 2025-12-31) — +Total Revenue: 11046000.00
CLST income_statement (quarterly, 2025-12-31) — +Total Revenue: 2625000.00
CLST balance_sheet (annual, 2025-12-31) — Accounts Receivable: 907000.00
CLST balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 907000.00
CLST balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4360000.00
CLST balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4360000.00
CLST balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 37363000.00
CLST balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 37363000.00
CLST cash_flow (annual, 2025-12-31) — Amortization Of Securities: 80000.00
CLST cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 20000.00
CLST cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 120000.00
CLST cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 14000.00
CLST balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1579000.00
CLST balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1579000.00
CLST income_statement (annual, 2025-12-31) — Basic Average Shares: 3664286.00
CLST income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3507692.00
CLST income_statement (annual, 2025-12-31) — Basic EPS: 0.56
CLST income_statement (quarterly, 2025-12-31) — Basic EPS: 0.13
CLST cash_flow (annual, 2025-12-31) — Beginning Cash Position: 44295000.00
CLST cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 37271000.00
CLST balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 6223000.00
CLST balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 6223000.00
CLST cash_flow (annual, 2025-12-31) — Capital Expenditure: -188000.00
CLST cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3000.00
CLST balance_sheet (annual, 2025-12-31) — Capital Stock: 41000.00
CLST balance_sheet (quarterly, 2025-12-31) — Capital Stock: 41000.00
CLST balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 25205000.00
CLST balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 25205000.00
CLST balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 25205000.00
CLST balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 25205000.00
CLST balance_sheet (annual, 2025-12-31) — Cash Financial: 25205000.00
CLST balance_sheet (quarterly, 2025-12-31) — Cash Financial: 25205000.00
CLST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2014000.00
CLST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1905000.00
CLST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -24391000.00
CLST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -10958000.00
CLST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3287000.00
CLST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 797000.00
CLST cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -144000.00
CLST cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -37000.00
CLST cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -147000.00
CLST cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -71000.00
CLST cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -494000.00
CLST cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -134000.00
CLST cash_flow (annual, 2025-12-31) — Change In Working Capital: -785000.00
CLST cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -242000.00
CLST cash_flow (annual, 2025-12-31) — Changes In Cash: -19090000.00
CLST cash_flow (quarterly, 2025-12-31) — Changes In Cash: -12066000.00
CLST balance_sheet (annual, 2025-12-31) — Common Stock: 41000.00
CLST balance_sheet (quarterly, 2025-12-31) — Common Stock: 41000.00
CLST balance_sheet (annual, 2025-12-31) — Common Stock Equity: 81725000.00
CLST balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 81725000.00
CLST cash_flow (annual, 2025-12-31) — Common Stock Payments: -2586000.00
CLST cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -807000.00
CLST cash_flow (annual, 2025-12-31) — Deferred Income Tax: 312000.00
CLST cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 64000.00
CLST cash_flow (annual, 2025-12-31) — Deferred Tax: 312000.00
CLST cash_flow (quarterly, 2025-12-31) — Deferred Tax: 64000.00
CLST cash_flow (annual, 2025-12-31) — Depreciation: 422000.00
CLST cash_flow (quarterly, 2025-12-31) — Depreciation: 107000.00
CLST cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 422000.00
CLST cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 107000.00
CLST cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 422000.00
CLST cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 107000.00
CLST income_statement (annual, 2025-12-31) — Diluted Average Shares: 3664286.00
CLST income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3507692.00
CLST income_statement (annual, 2025-12-31) — Diluted EPS: 0.56
CLST income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.13
CLST income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 456000.00
CLST cash_flow (annual, 2025-12-31) — End Cash Position: 25205000.00
CLST cash_flow (quarterly, 2025-12-31) — End Cash Position: 25205000.00
CLST cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2014000.00
CLST cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1905000.00
CLST cash_flow (annual, 2025-12-31) — Free Cash Flow: 3099000.00
CLST cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 794000.00
CLST cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 1000.00
CLST cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CLST income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 0.00
CLST income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
CLST balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2409000.00
CLST balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2409000.00
CLST income_statement (annual, 2025-12-31) — General And Administrative Expense: 5630000.00
CLST income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1457000.00
CLST balance_sheet (annual, 2025-12-31) — Gross PPE: 10210000.00
CLST balance_sheet (quarterly, 2025-12-31) — Gross PPE: 10210000.00
CLST balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 14917000.00
CLST balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 14917000.00
CLST cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 116000.00
CLST cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 50000.00
CLST income_statement (annual, 2025-12-31) — Interest Expense: 4106000.00
CLST income_statement (quarterly, 2025-12-31) — Interest Expense: 1041000.00
CLST income_statement (annual, 2025-12-31) — Interest Income: 13896000.00
CLST income_statement (quarterly, 2025-12-31) — Interest Income: 3548000.00
CLST cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3980000.00
CLST cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1030000.00
CLST balance_sheet (annual, 2025-12-31) — Invested Capital: 96457000.00
CLST balance_sheet (quarterly, 2025-12-31) — Invested Capital: 96457000.00
CLST cash_flow (annual, 2025-12-31) — Investing Cash Flow: -24391000.00
CLST cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -10958000.00
CLST balance_sheet (annual, 2025-12-31) — Investments And Advances: 65384000.00
CLST balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 65384000.00
CLST cash_flow (annual, 2025-12-31) — Issuance Of Debt: 33251000.00
CLST cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 28250000.00
CLST balance_sheet (annual, 2025-12-31) — Land And Improvements: 1767000.00
CLST balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1767000.00
CLST balance_sheet (annual, 2025-12-31) — Long Term Debt: 14732000.00
CLST balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 14732000.00
CLST balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 14732000.00
CLST balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 14732000.00
CLST cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 33251000.00
CLST cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 28250000.00
CLST cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -28251000.00
CLST cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -28250000.00
CLST balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2121000.00
CLST balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2121000.00
CLST cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2586000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -807000.00
CLST income_statement (annual, 2025-12-31) — Net Income: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 456000.00
CLST cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2052000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2052000.00
CLST income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 456000.00
CLST income_statement (annual, 2025-12-31) — Net Interest Income: 9790000.00
CLST income_statement (quarterly, 2025-12-31) — Net Interest Income: 2507000.00
CLST cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -21852000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -5303000.00
CLST cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 5000000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CLST cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 5000000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CLST cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 925000.00
CLST cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -167000.00
CLST balance_sheet (annual, 2025-12-31) — Net PPE: 5850000.00
CLST balance_sheet (quarterly, 2025-12-31) — Net PPE: 5850000.00
CLST cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -188000.00
CLST cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -3000.00
CLST balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 81725000.00
CLST balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 81725000.00
CLST income_statement (annual, 2025-12-31) — Normalized Income: 2052819.00
CLST income_statement (quarterly, 2025-12-31) — Normalized Income: 634758.62
CLST income_statement (annual, 2025-12-31) — Occupancy And Equipment: 823000.00
CLST income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 196000.00
CLST cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3287000.00
CLST cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 797000.00
CLST cash_flow (annual, 2025-12-31) — Operating Gains Losses: -45000.00
CLST cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -5000.00
CLST income_statement (annual, 2025-12-31) — Operating Revenue: 11046000.00
CLST income_statement (quarterly, 2025-12-31) — Operating Revenue: 2625000.00
CLST balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 4074911.00
CLST balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 4074911.00
CLST balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2409000.00
CLST balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2409000.00
CLST balance_sheet (annual, 2025-12-31) — Other Equity Interest: -5182000.00
CLST balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -5182000.00
CLST cash_flow (annual, 2025-12-31) — Other Non Cash Items: 174000.00
CLST cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 39000.00
CLST income_statement (annual, 2025-12-31) — Other Non Interest Expense: 1493000.00
CLST income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 190000.00
CLST balance_sheet (annual, 2025-12-31) — Other Properties: 99000.00
CLST balance_sheet (quarterly, 2025-12-31) — Other Properties: 99000.00
CLST balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 48888000.00
CLST balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 48888000.00
CLST income_statement (annual, 2025-12-31) — Other Special Charges: 1000.00
CLST income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
CLST balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CLST balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CLST income_statement (annual, 2025-12-31) — Pretax Income: 2504000.00
CLST income_statement (quarterly, 2025-12-31) — Pretax Income: 551000.00
CLST income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 404000.00
CLST income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 98000.00
CLST cash_flow (annual, 2025-12-31) — Purchase Of Investment: -26497000.00
CLST cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -7463000.00
CLST cash_flow (annual, 2025-12-31) — Purchase Of PPE: -188000.00
CLST cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -3000.00
CLST balance_sheet (annual, 2025-12-31) — Receivables: 907000.00
CLST balance_sheet (quarterly, 2025-12-31) — Receivables: 907000.00
CLST income_statement (annual, 2025-12-31) — Reconciled Depreciation: 422000.00
CLST income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 107000.00
CLST cash_flow (annual, 2025-12-31) — Repayment Of Debt: -28251000.00
CLST cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -28250000.00
CLST cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2586000.00
CLST cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -807000.00
CLST balance_sheet (annual, 2025-12-31) — Retained Earnings: 51912000.00
CLST balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 51912000.00
CLST income_statement (annual, 2025-12-31) — Salaries And Wages: 5630000.00
CLST income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1457000.00
CLST cash_flow (annual, 2025-12-31) — Sale Of Investment: 4645000.00
CLST cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 2160000.00
CLST cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
CLST cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CLST income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 131000.00
CLST income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 37000.00
CLST income_statement (annual, 2025-12-31) — Selling General And Administration: 5761000.00
CLST income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1494000.00
CLST balance_sheet (annual, 2025-12-31) — Share Issued: 4074911.00
CLST balance_sheet (quarterly, 2025-12-31) — Share Issued: 4074911.00
CLST income_statement (annual, 2025-12-31) — Special Income Charges: -1000.00
CLST income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CLST cash_flow (annual, 2025-12-31) — Stock Based Compensation: 897000.00
CLST cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 248000.00
CLST balance_sheet (annual, 2025-12-31) — Stockholders Equity: 81725000.00
CLST balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 81725000.00
CLST balance_sheet (annual, 2025-12-31) — Tangible Book Value: 81725000.00
CLST balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 81725000.00
CLST income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -181.00
CLST income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -37241.38
CLST income_statement (annual, 2025-12-31) — Tax Provision: 452000.00
CLST income_statement (quarterly, 2025-12-31) — Tax Provision: 95000.00
CLST income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.18
CLST income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
CLST balance_sheet (annual, 2025-12-31) — Total Assets: 282927000.00
CLST balance_sheet (quarterly, 2025-12-31) — Total Assets: 282927000.00
CLST balance_sheet (annual, 2025-12-31) — Total Capitalization: 96457000.00
CLST balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 96457000.00
CLST balance_sheet (annual, 2025-12-31) — Total Debt: 14732000.00
CLST balance_sheet (quarterly, 2025-12-31) — Total Debt: 14732000.00
CLST balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 81725000.00
CLST balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 81725000.00
CLST balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 201202000.00
CLST balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 201202000.00
CLST income_statement (annual, 2025-12-31) — Total Unusual Items: -1000.00
CLST income_statement (quarterly, 2025-12-31) — Total Unusual Items: -216000.00
CLST income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1000.00
CLST income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -216000.00
CLST income_statement (quarterly, 2026-03-31) — +Total Revenue: 2897000.00
CLST balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 849000.00
CLST balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 37303000.00
CLST cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 17000.00
CLST cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
CLST balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1548000.00
CLST income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3487500.00
CLST income_statement (quarterly, 2026-03-31) — Basic EPS: 0.16
CLST cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 25205000.00
CLST cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4000.00
CLST balance_sheet (quarterly, 2026-03-31) — Capital Stock: 41000.00
CLST balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 38533000.00
CLST balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 38533000.00
CLST balance_sheet (quarterly, 2026-03-31) — Cash Financial: 38533000.00
CLST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 4839000.00
CLST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 7828000.00
CLST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 661000.00
CLST cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -191000.00
CLST cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 6000.00
CLST cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -134000.00
CLST cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -319000.00
CLST cash_flow (quarterly, 2026-03-31) — Changes In Cash: 13328000.00
CLST balance_sheet (quarterly, 2026-03-31) — Common Stock: 41000.00
CLST balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 82209000.00
CLST cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -260000.00
CLST cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 97000.00
CLST cash_flow (quarterly, 2026-03-31) — Deferred Tax: 97000.00
CLST cash_flow (quarterly, 2026-03-31) — Depreciation: 105000.00
CLST cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 105000.00
CLST cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 105000.00
CLST income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3720000.00
CLST income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.15
CLST income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 558000.00
CLST cash_flow (quarterly, 2026-03-31) — End Cash Position: 38533000.00
CLST cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 4839000.00
CLST cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 657000.00
CLST balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2476000.00
CLST income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1442000.00
CLST balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 14914000.00
CLST income_statement (quarterly, 2026-03-31) — Interest Expense: 1025000.00
CLST income_statement (quarterly, 2026-03-31) — Interest Income: 3570000.00
CLST cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1034000.00
CLST balance_sheet (quarterly, 2026-03-31) — Invested Capital: 91968000.00
CLST cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 7828000.00
CLST balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 63130000.00
CLST cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 4000000.00
CLST balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 9759000.00
CLST balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9759000.00
CLST cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 4000000.00
CLST cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -9000000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -260000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 558000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Net Interest Income: 2545000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 2153000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -5000000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -5000000.00
CLST cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -817000.00
CLST balance_sheet (quarterly, 2026-03-31) — Net PPE: 5749000.00
CLST cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4000.00
CLST balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 82209000.00
CLST income_statement (quarterly, 2026-03-31) — Normalized Income: 558000.00
CLST income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 209000.00
CLST cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 661000.00
CLST cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -7000.00
CLST income_statement (quarterly, 2026-03-31) — Operating Revenue: 2897000.00
CLST balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 4058297.00
CLST balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2476000.00
CLST balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -5129000.00
CLST cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 27000.00
CLST income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 414000.00
CLST balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 46668000.00
CLST balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CLST income_statement (quarterly, 2026-03-31) — Pretax Income: 684000.00
CLST income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 185000.00
CLST cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CLST cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4000.00
CLST balance_sheet (quarterly, 2026-03-31) — Receivables: 849000.00
CLST income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 105000.00
CLST cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -9000000.00
CLST cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -260000.00
CLST balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 52470000.00
CLST income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1442000.00
CLST cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 2153000.00
CLST income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 33000.00
CLST income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1475000.00
CLST balance_sheet (quarterly, 2026-03-31) — Share Issued: 4058297.00
CLST cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 253000.00
CLST balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 82209000.00
CLST balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 82209000.00
CLST income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLST income_statement (quarterly, 2026-03-31) — Tax Provision: 126000.00
CLST income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
CLST balance_sheet (quarterly, 2026-03-31) — Total Assets: 288508000.00
CLST balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 91968000.00
CLST balance_sheet (quarterly, 2026-03-31) — Total Debt: 9759000.00
CLST balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 82209000.00
CLST balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 206299000.00
CLTN.SW balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 227000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -17924000.00
CLTN.SW balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 156000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Issuance Of Debt: 4500000.00
CLTN.SW balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 71000.00
CLTN.SW balance_sheet (annual, 2021-12-31) — Long Term Debt: 4000.00
CLTN.SW balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 75000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 4500000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -22125000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CLTN.SW cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -17625000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -17625000.00
CLTN.SW income_statement (annual, 2021-12-31) — Other Operating Expenses: 1000.00
CLTN.SW income_statement (annual, 2021-12-31) — Other Special Charges: 1000.00
CLTN.SW cash_flow (annual, 2021-12-31) — Repayment Of Debt: -22125000.00
CLTN.SW income_statement (annual, 2021-12-31) — Special Income Charges: -1000.00
CLTN.SW income_statement (annual, 2021-12-31) — Total Unusual Items: -1000.00
CLTN.SW income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -1000.00
CLTN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 133501000.00
CLTN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 267125000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 8306000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 38388000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -77136000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -817000.00
CLTN.SW income_statement (annual, 2022-12-31) — Amortization: 1372000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1372000.00
CLTN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 5974550.00
CLTN.SW income_statement (annual, 2022-12-31) — Basic EPS: 4.35
CLTN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 25733000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 46085000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -8318000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 67000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 598000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 24224000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 24224000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -19716000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -2855000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1539000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Change In Payable: -3668000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -2735000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -11679000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: -704000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 598000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -19716000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 112184000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 2539000.00
CLTN.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 98713000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 133135000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 67000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Debt: 47005000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 47072000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 73075000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 1143000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Depreciation: 5343000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 6715000.00
CLTN.SW income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 6715000.00
CLTN.SW income_statement (annual, 2022-12-31) — Depreciation Income Statement: 5343000.00
CLTN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 5974550.00
CLTN.SW income_statement (annual, 2022-12-31) — Diluted EPS: 4.35
CLTN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — EBIT: 33167000.00
CLTN.SW income_statement (annual, 2022-12-31) — EBITDA: 39882000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -805000.00
CLTN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 24224000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: -15928000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 33809000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 15103000.00
CLTN.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 24838000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6241000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 39205000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 125777000.00
CLTN.SW income_statement (annual, 2022-12-31) — Gross Profit: 168412000.00
CLTN.SW income_statement (annual, 2022-12-31) — Interest Expense: 232000.00
CLTN.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 232000.00
CLTN.SW income_statement (annual, 2022-12-31) — Interest Income: 34000.00
CLTN.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 34000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -232000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Interest Received Cfo: 43000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -12290000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Inventory: 62816000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 159189000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8197000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 37017000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Land And Improvements: 3091000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 0.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CLTN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 37017000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -32876000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2461000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 74062000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -353000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Net Debt: 22781000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 25999000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 25999000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 25999000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2830000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -198000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4141000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4141000.00
CLTN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -198000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 4141000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 48641000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -5367000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 105943000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2210000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2877000.00
CLTN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 39882000.00
CLTN.SW income_statement (annual, 2022-12-31) — Normalized Income: 25999000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 23421000.00
CLTN.SW income_statement (annual, 2022-12-31) — Operating Income: 34911000.00
CLTN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 267125000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 5975012.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1324000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Equity Interest: -225874000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 6241000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: 8815000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Assets: -1000.00
CLTN.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 113000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 745000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 767000.00
CLTN.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Payables: 16327000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2193000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 5078000.00
CLTN.SW income_statement (annual, 2022-12-31) — Pretax Income: 32935000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLTN.SW cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2830000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -5488000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 29215000.00
CLTN.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 98713000.00
CLTN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 6715000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -32876000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 224550000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 121000.00
CLTN.SW income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 8604000.00
CLTN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 33442000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 5975580.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 112184000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 105943000.00
CLTN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLTN.SW income_statement (annual, 2022-12-31) — Tax Provision: 6936000.00
CLTN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CLTN.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1862000.00
CLTN.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -6240000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 190597000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 112184000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 47072000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 112184000.00
CLTN.SW income_statement (annual, 2022-12-31) — Total Expenses: 232214000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 78413000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 57462000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5338000.00
CLTN.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 34911000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 7276000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 568.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 45000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Work In Process: 12082000.00
CLTN.SW balance_sheet (annual, 2022-12-31) — Working Capital: 60060000.00
CLTN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 127206000.00
CLTN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 242729000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 11146000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 35389000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -69600000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -816000.00
CLTN.SW income_statement (annual, 2023-12-31) — Amortization: 1457000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1457000.00
CLTN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 5975156.00
CLTN.SW income_statement (annual, 2023-12-31) — Basic EPS: 2.00
CLTN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 24224000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 43689000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -8684000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 598000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 18360000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 18360000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -19711000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 1968000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1499000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Change In Payable: 3470000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 1062000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: 7884000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: -4520000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 598000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 96874000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 3657000.00
CLTN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 95915000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 118104000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Debt: 45000000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 45000000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 73633000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 943000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Depreciation: 5392000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 6849000.00
CLTN.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 6849000.00
CLTN.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 5392000.00
CLTN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 5975156.00
CLTN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 2.00
CLTN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 11947000.00
CLTN.SW income_statement (annual, 2023-12-31) — EBIT: 16955000.00
CLTN.SW income_statement (annual, 2023-12-31) — EBITDA: 23804000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1344000.00
CLTN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 18360000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -21935000.00
CLTN.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 29714000.00
CLTN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 17292000.00
CLTN.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 23048000.00